USFDA conducts audit of Stride Alathur's formulations unit

Strides Pharma Science announced that a routine current Good Manufacturing Practices (cGMP) inspection was conducted by the United States Food and Drug Administration (USFDA) at the Formulations Facility
of Strides Alathur, a wholly owned subsidiary of the Company, at Alathur, Chennai during the week of 01 April 2024 to 05 April 2024. The inspection closed with two observations.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Apr 06 2024 | 4:50 PM IST
